News / Articles

Medical Mondays is designed for startups, investors, researchers, health systems, and incubators. Our mission is to connect healthcare startups and companies with the capital and partnerships they need to succeed.

This exclusive track includes small-group breakfasts with investors and featured placement in the pre-event investor scouting report.

If your goal is to raise capital, apply for the new Funding Fast Track at LSI USA '26: March 16-20, 2026 in Waldorf Astoria, Monarch Beach.

The NMF DCTR program trains doctors committed to investigating treatment and preventative regimens across all populations. The comprehensive program features a clinical investigator certification course to provide health care professionals with the core knowledge, skills, and competencies needed to engage in clinical trial activities.

Non-dilutive funding: Wearable biosensors

Providing non-dilutive funding awards for proof-of-concept studies that support the development, evaluation and validation of wearable biosensors for medical countermeasures, focusing on the detection or monitoring of emerging infectious diseases within BARDA's mission space.

Non-dilutive funding: Traumatic brain injury solutions

Providing non-dilutive funding for advanced development of digital tools for assessing traumatic brain injury (TBI) as a medical consequence of nuclear detonation and other blast events.

Digital health solutions are playing a crucial role in enhancing public health preparedness and response capabilities. In the face of evolving global health security threats, the integration of digital technologies has proven to be essential for rapid diagnosis, real-time data sharing and informed decision-making across healthcare systems.

The Paratus Digital Health Accelerator-BARDA Accelerator Network Hub for Digital Health program provides comprehensive support to digital health companies to build and scale their solutions. This support is provided at no cost to program participants.

Biodesign Innovation Fellows are dynamic high-performers with backgrounds in healthcare, engineering, computer science, or business. Working in multidisciplinary teams in this hands-on, full-time program, fellows learn how to identify important unmet medical needs, invent technologies to address them, and bring those products into patient care.

Applications are open through July 28, 2025.

MedTech Color members now have access to Medical Device Development: Advancing from Product to Market (MDD), an On-Demand Course by Harvard Catalyst.

The future of healthcare is being reshaped by AI and technology—you can be part of the transformation! Rubitection is disrupting skin health detection for aging and chronic care patients, preventing diabetic foot ulcers, pressure injuries, and more in the area of chronic dermatology. Backed by AARP AgeTech, Pipeline Angels, and TechStars, interest from leading hospital facilities, and positive initial patient data, we're building strong momentum. Invest today into Rubitection to be a part of this great investment on Wefunder and be in the first group of supporters to join this life-saving, high-impact technology! Don’t forget to share it with your friends!

The University System of Maryland Launch Fund is a three-year pilot program comprised of $600,000 which is being distributed by System institutions as microgrants to companies and organizations founded by students, faculty, employees, or alumni. Ventures are required to have a substantial portion of their manufacturing, service, research and development, or office space located in Maryland. Apply by June 15.

Start-up founders whose companies operate at the intersection of health, tech, and artificial intelligence are encouraged to apply to the Techstars AI Health Baltimore Accelerator powered by Johns Hopkins University and CareFirst BlueCross BlueShield. Selected applicants will gain support and mentorship from Techstars, Johns Hopkins, and CareFirst.

Apply by June 11.

Join Milken Institute for an interactive virtual public convening, Defining the Value and ROI of Patient Engagement in Medtech Product Development, to provide public comments on a draft framework that outlines how and where patient engagement can drive impact across the total product lifecycle of medtech R&D activities—from early-stage development to post-market decisions. This convening will also feature a set of medical device and patient organization presenters sharing their experiences engaging patients in their R&D activities and describe the impact of doing so.

A new whitepaper from the founders of LeagueMed provides a practical overview of how to transform early-stage MedTech innovations into viable companies. The paper, titled “Financing the Medtech Journey: From Innovation to Commercialization,” details the foundational steps of company formation, licensing, product development, and clinical trials, as well as the funding strategies that drive growth in sectors such as pharmaceuticals, medical devices, and digital health.

Stage Zero is excited to open office hours for MedTech specific founder support, which include corporate strategic partnerships, fundraising, analyzing competitive landscapes, or just founder-to-founder chats.